Comparative Pharmacology
Head-to-head clinical analysis: ACTICLATE CAP versus DYNA HEX 2.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ACTICLATE CAP versus DYNA HEX 2.
ACTICLATE CAP vs DYNA-HEX 2
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, blocking aminoacyl-tRNA binding.
Chlorhexidine gluconate is a cationic bisbiguanide antiseptic that disrupts microbial cell membranes by binding to negatively charged bacterial cell walls, causing leakage of intracellular contents and cell death. It has broad-spectrum activity against gram-positive and gram-negative bacteria, fungi, and some viruses.
350 mg orally once daily, increased to 350 mg twice daily if no response after 2 weeks.
1-2 mg IV/IM every 4-6 hours as needed for anxiety, up to 10 mg/day.
None Documented
None Documented
Terminal elimination half-life 6-10 hours; prolonged in renal impairment (up to 22 hours in anuria)
2-4 hours; prolonged in renal impairment (up to 10-12 hours in anuria).
Renal (60-70% as unchanged drug), fecal (20-30% as metabolites); minor biliary elimination
Primarily renal (70-80% unchanged) with minor biliary excretion (<5%) and fecal elimination (<5%).
Category C
Category C
Tetracycline Antibiotic
Tetracycline Antibiotic